These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25460333)

  • 21. Reliability of dynamic contrast-enhanced magnetic resonance imaging data in primary brain tumours: a comparison of Tofts and shutter speed models.
    Inglese M; Ordidge KL; Honeyfield L; Barwick TD; Aboagye EO; Waldman AD; Grech-Sollars M
    Neuroradiology; 2019 Dec; 61(12):1375-1386. PubMed ID: 31392385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selection of Fitting Model and Arterial Input Function for Repeatability in Dynamic Contrast-Enhanced Prostate MRI.
    Peled S; Vangel M; Kikinis R; Tempany CM; Fennessy FM; Fedorov A
    Acad Radiol; 2019 Sep; 26(9):e241-e251. PubMed ID: 30467073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simulating the effect of input errors on the accuracy of Tofts' pharmacokinetic model parameters.
    Lavini C
    Magn Reson Imaging; 2015 Feb; 33(2):222-35. PubMed ID: 25308097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Joint arterial input function and tracer kinetic parameter estimation from undersampled dynamic contrast-enhanced MRI using a model consistency constraint.
    Guo Y; Lingala SG; Bliesener Y; Lebel RM; Zhu Y; Nayak KS
    Magn Reson Med; 2018 May; 79(5):2804-2815. PubMed ID: 28905411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations.
    Joint Head and Neck Radiotherapy-MRI Development Cooperative
    Sci Rep; 2017 Sep; 7(1):11185. PubMed ID: 28894197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II.
    Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Kinahan PE; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
    Tomography; 2019 Mar; 5(1):99-109. PubMed ID: 30854447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPU-accelerated nonparametric kinetic analysis of DCE-MRI data from glioblastoma patients treated with bevacizumab.
    Hsu YH; Ferl GZ; Ng CM
    Magn Reson Imaging; 2013 May; 31(4):618-23. PubMed ID: 23200680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
    Ginsburg SB; Taimen P; Merisaari H; Vainio P; Boström PJ; Aronen HJ; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2016 Dec; 44(6):1405-1414. PubMed ID: 27285161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arterial input function calculation in dynamic contrast-enhanced MRI: an in vivo validation study using co-registered contrast-enhanced ultrasound imaging.
    Mehrabian H; Chandrana C; Pang I; Chopra R; Martel AL
    Eur Radiol; 2012 Aug; 22(8):1735-47. PubMed ID: 22752523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying dynamic contrast-enhanced MRI of the knee in children with juvenile rheumatoid arthritis using an arterial input function (AIF) extracted from popliteal artery enhancement, and the effect of the choice of the AIF on the kinetic parameters.
    Workie DW; Dardzinski BJ
    Magn Reson Med; 2005 Sep; 54(3):560-8. PubMed ID: 16088875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic Contrast-enhanced MR Imaging in Renal Cell Carcinoma: Reproducibility of Histogram Analysis on Pharmacokinetic Parameters.
    Wang HY; Su ZH; Xu X; Sun ZP; Duan FX; Song YY; Li L; Wang YW; Ma X; Guo AT; Ma L; Ye HY
    Sci Rep; 2016 Jul; 6():29146. PubMed ID: 27380733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The arterial input function: Spatial dependence within the imaging volume and its influence on 3D quantitative dynamic contrast-enhanced MRI for head and neck cancer.
    Roberts J; Kim SE; Kholmovski EG; Hitchcock Y; Richards TJ; Anzai Y
    Magn Reson Imaging; 2023 Sep; 101():40-46. PubMed ID: 37030177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of arterial input function selection on kinetic parameters in brain dynamic contrast-enhanced MRI.
    Keil VC; Mädler B; Gieseke J; Fimmers R; Hattingen E; Schild HH; Hadizadeh DR
    Magn Reson Imaging; 2017 Jul; 40():83-90. PubMed ID: 28438713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI.
    Cheng HL
    J Magn Reson Imaging; 2008 Sep; 28(3):736-43. PubMed ID: 18777534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy and precision of quantitative DCE-MRI parameters: How should one estimate contrast concentration?
    Wake N; Chandarana H; Rusinek H; Fujimoto K; Moy L; Sodickson DK; Kim SG
    Magn Reson Imaging; 2018 Oct; 52():16-23. PubMed ID: 29777820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimation of pharmacokinetic parameters from DCE-MRI by extracting long and short time-dependent features using an LSTM network.
    Zou J; Balter JM; Cao Y
    Med Phys; 2020 Aug; 47(8):3447-3457. PubMed ID: 32379942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerated Brain DCE-MRI Using Iterative Reconstruction With Total Generalized Variation Penalty for Quantitative Pharmacokinetic Analysis: A Feasibility Study.
    Wang C; Yin FF; Kirkpatrick JP; Chang Z
    Technol Cancer Res Treat; 2017 Aug; 16(4):446-460. PubMed ID: 27215931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
    Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
    Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors.
    Rijpkema M; Kaanders JH; Joosten FB; van der Kogel AJ; Heerschap A
    J Magn Reson Imaging; 2001 Oct; 14(4):457-63. PubMed ID: 11599071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study.
    Miyazaki K; Jerome NP; Collins DJ; Orton MR; d'Arcy JA; Wallace T; Moreno L; Pearson AD; Marshall LV; Carceller F; Leach MO; Zacharoulis S; Koh DM
    Eur Radiol; 2015 Sep; 25(9):2641-50. PubMed ID: 25773937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.